Research Catalyst Program
Topic Area: Ming Hsieh Institute Research
The Ming Hsieh Institute for Research on Engineering-Medicine for Cancer (MHI) sponsors the Ming Hsieh Institute Research Award, which aims to make USC an international leader in translational research that bridges basic science, engineering, computing, and medicine.
The MHI’s main goal is to support integrated interdisciplinary translational research that speeds discovery and creates pathways to rapidly improve the lives of cancer patients.
Ming Hsieh Institute Research topic area funds innovative interdisciplinary projects that integrate engineering, computing, and medicine to accelerate translational discoveries. The program supports novel therapeutic and diagnostic approaches, fosters collaborations between technical and clinical researchers, and advances technologies with strong potential for commercialization and improving human health.The program supports research that expedites the bench-to-bedside development of new life-saving devices and therapeutics to detect and/or treat cancer.
As a donor-restricted program, awards are capped at $150,000 for Pre-Clinical Studies and $250,000 for Translational Research Projects, with proposals in either category that include a significant AI component eligible to request an additional $100,000; donor terms also require that at least one PI or co-PI hold a primary appointment in the Viterbi School of Engineering.
- Pre-Clinical Study: Lead PI from engineering, computing, AI/ML, computational biology, physics, chemistry, biology, molecular biology, or related sciences, partnered with biomedical researchers (may include pharmacy or dentistry). At least one physician (M.D.) must serve as co-PI or advisor with active clinical practice in the relevant cancer area.
- Translational Research Project: Lead PI must be a physician (M.D. or M.D./Ph.D.) whose current clinical practice includes serving patients in the area of the specific disease for which the research is proposed. Teams should be multidisciplinary and include researchers from engineering, computing, AI/ML, computational biology, physics, chemistry, biology, molecular biology, or related sciences.
If you are experiencing technical issues submitting your proposal or have additional questions, please contact the rii@usc.edu.
This portal requires information about the PIs and Co-PIs in addition to department and contact information, including the 10-digit USC ID#. Please have this material prepared before beginning this application.
RCP - MHI
Research Catalyst Program
Topic Area: Ming Hsieh Institute Research
The Ming Hsieh Institute for Research on Engineering-Medicine for Cancer (MHI) sponsors the Ming Hsieh Institute Research Award, which aims to make USC an international leader in translational research that bridges basic science, engineering, computing, and medicine.
The MHI’s main goal is to support integrated interdisciplinary translational research that speeds discovery and creates pathways to rapidly improve the lives of cancer patients.
Ming Hsieh Institute Research topic area funds innovative interdisciplinary projects that integrate engineering, computing, and medicine to accelerate translational discoveries. The program supports novel therapeutic and diagnostic approaches, fosters collaborations between technical and clinical researchers, and advances technologies with strong potential for commercialization and improving human health.The program supports research that expedites the bench-to-bedside development of new life-saving devices and therapeutics to detect and/or treat cancer.
As a donor-restricted program, awards are capped at $150,000 for Pre-Clinical Studies and $250,000 for Translational Research Projects, with proposals in either category that include a significant AI component eligible to request an additional $100,000; donor terms also require that at least one PI or co-PI hold a primary appointment in the Viterbi School of Engineering.
- Pre-Clinical Study: Lead PI from engineering, computing, AI/ML, computational biology, physics, chemistry, biology, molecular biology, or related sciences, partnered with biomedical researchers (may include pharmacy or dentistry). At least one physician (M.D.) must serve as co-PI or advisor with active clinical practice in the relevant cancer area.
- Translational Research Project: Lead PI must be a physician (M.D. or M.D./Ph.D.) whose current clinical practice includes serving patients in the area of the specific disease for which the research is proposed. Teams should be multidisciplinary and include researchers from engineering, computing, AI/ML, computational biology, physics, chemistry, biology, molecular biology, or related sciences.
If you are experiencing technical issues submitting your proposal or have additional questions, please contact the rii@usc.edu.
This portal requires information about the PIs and Co-PIs in addition to department and contact information, including the 10-digit USC ID#. Please have this material prepared before beginning this application.